Literature DB >> 18669260

[Synthesis of 2-chloro-2'-deoxyadenosine by microbiological transglycosylation using a recombinant Escherichia coli strain].

S A Taran, K N Verevkina, T Z Esikova, S A Feofanov, A I Miroshnikov.   

Abstract

Cladribine (2-chloro-2'-deoxyadenosine) was synthesized using intact cells of the recombinant Escherichia coli strain producing Geobacillus stearothermophilus B-2194 thermostable purine-nucleoside phosphorylase II (EC 2.4.2.1). Use of the cells containing this thermostable enzyme allowed the process to be conducted at a temperature of 70 degrees C, which provided the maximal concentrations of sparingly soluble substrates. The best results were obtained with 2-chloroadenine as a modified base. The highest yield of the target 2-chloro-2'-deoxyadenosine (up to 95% in the case of deoxyguanosine) was reached when using 2'-deoxypurines as donors of deoxyribose. Use of thymidine for these purposes required its considerable molar excess over 2-chloroadenine (up to 6 : 1), which is connected with a nonoptimal amount of endogenous thymidine phosphorylase, necessary for synthesis of deoxyribose-1-phosphate, in the transglycosylation reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669260

Source DB:  PubMed          Journal:  Prikl Biokhim Mikrobiol        ISSN: 0555-1099


  2 in total

1.  Improved synthesis of 2'-deoxyadenosine and 5-methyluridine by Escherichia coli using an auto-induction system.

Authors:  Juan Xiong; Wenquan Zhang; Jingtan Su; Junlong Shangguan; Yin Lin; Yang Yang; Rongqing Zhang; Liping Xie; Hongzhong Wang
Journal:  World J Microbiol Biotechnol       Date:  2011-09-14       Impact factor: 3.312

2.  Cladribine Analogues via O⁶-(Benzotriazolyl) Derivatives of Guanine Nucleosides.

Authors:  Sakilam Satishkumar; Prasanna K Vuram; Siva Subrahmanyam Relangi; Venkateshwarlu Gurram; Hong Zhou; Robert J Kreitman; Michelle M Martínez Montemayor; Lijia Yang; Muralidharan Kaliyaperumal; Somesh Sharma; Narender Pottabathini; Mahesh K Lakshman
Journal:  Molecules       Date:  2015-10-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.